<prompt> Patisiran was approved by FDA recently forFilariasisPeripheral NeuropathyNeuropathy of diabetesNeuropathy of amyloidosis  <response>: It is a double stranded small interfering ribose neuclic acid si RNA formulated in the form of a lipid complex. used in the treatment of polyneuropathy 